Table 1 Patients' characteristics
No of patients | % | |
|---|---|---|
Number of patients enrolled | 53 | |
Age (years) | ||
Median (range) | 65 (18 – 78) | |
Sex | ||
Male | 30 | 56.6 |
Female | 23 | 43.4 |
Performance status (WHO) | ||
0 | 26 | 49 |
1 | 20 | 37.7 |
2 | 7 | 13.2 |
Tumor Origin | ||
Colon | 36 | 67.9 |
Rectum | 17 | 32.1 |
Prior Treatment | ||
Surgery | 39 | 73.6 |
Adjuvant chemotherapy | 13 | 24.5 |
Adjuvant radiotherapy | 6 | 11.3 |
Abnormal ALP # level at baseline | 21 | 39.6 |
Abnormal WBC^ level at baseline | 10 | 18.9 |
Abnormal PLT* level at baseline | 6 | 11.3 |
Kohne prognostic index | ||
Low risk | 11 | 20.7 |
Intermediate risk | 30 | 56.6 |
High risk | 12 | 22.6 |
Sites of disease | ||
Local Abdominal Mass | 11 | 20.7 |
Liver | 34 | 64.2 |
Lung | 18 | 34 |
Lymph Nodes | 17 | 32 |
Number of metastatic sites | ||
1 | 14 | 26.4 |
2 | 30 | 56.6 |
≥ 3 median | 9 | 17 |
Median (range) | 2 (1–5) | |